These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30633324)

  • 1. Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Thorel D; Delcampe A; Ingen-Housz-Oro S; Hajj C; Gabison E; Chosidow O; Wolkenstein P; Royer G; Ezzedine K; Muraine M; Gueudry J
    Br J Dermatol; 2019 Jul; 181(1):212-213. PubMed ID: 30633324
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular manifestations in patients with Stevens-Johnson syndrome in Malawi-review of the literature illustrated by clinical cases.
    Schulze Schwering M; Kayange P; Rothe C
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2343-2348. PubMed ID: 31352606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
    Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
    Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ophthalmic manifestations after Lyell and Stevens-Johnson syndromes].
    Mouafik SB; Hocar O; Akhdari N; Amal S; Belghmaidi S; Ennassiri W; Hajji I; Moutaouakil A
    Ann Dermatol Venereol; 2015; 142(6-7):393-8. PubMed ID: 25896732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis.
    Sotozono C; Ueta M; Kinoshita S
    Arch Dermatol; 2009 Nov; 145(11):1336-7; author reply 1337-8. PubMed ID: 19917974
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis.
    Yoshikawa Y; Ueta M; Nishigaki H; Kinoshita S; Ikeda T; Sotozono C
    Sci Rep; 2020 Nov; 10(1):18922. PubMed ID: 33144639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular manifestation, complications and aetiological factors in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chhipa SA; Masood S; Salarzai Y; Khan QA; Ahmad K; Sajid S
    J Pak Med Assoc; 2015 Jan; 65(1):62-4. PubMed ID: 25831677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stevens-Johnson and Lyell syndromes: mucocutaneous and ocular sequels in 43 cases].
    Fellahi A; Zouhair K; Amraoui A; Benchikhi H
    Ann Dermatol Venereol; 2011 Feb; 138(2):88-92. PubMed ID: 21333817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K;
    Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population.
    Kannabiran C; Ueta M; Sangwan V; Rathi V; Basu S; Tokunaga K; Kinoshita S
    Sci Rep; 2017 Nov; 7(1):15960. PubMed ID: 29162886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ukponmwan CU; Njinaka I; Ehimiyen ET
    Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Saito K; Ueta M; Maekawa K; Sotozono C; Kinoshita S; Saito Y
    PLoS One; 2016; 11(11):e0167402. PubMed ID: 27898730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Tian XB; Liu W; Zhang LX
    J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.